Mahase E (2022)
Rybelsus (generic name: oral semaglutide) is the worlds first oral GLP-1 receptor agonist
Hsu et al used the TriNetX platform to study the association between semaglutide use and the incidence of NAION and found that it was associated with an increased risk in patients with diabetes at the 2-, 3-, and 4-year timepoints but not within 1 year of GLP-1 RA initiation
The details ( Evidence, limitations, Mechanisms and massage for patients) in first 4 comments What this means for users/patients +If someone is being treated with semaglutide and has risk factors for optic nerve issues (for example: previous NAION in one eye, glaucoma, optic disc crowding, severe diabetic retinopathy, major vascular disease), then this potential risk should be discussed with their ophthalmologist and prescribing physician
Try gentle swirling, and if it persists, switch to acetic acid water
These shifts can affect other hormones in your body as well, including those related to stress and energy balance